May 29, 2026 a 07:46 am
ELV: Dividend Analysis - Elevance Health Inc.
Elevance Health Inc. (ELV) currently exhibits a robust dividend profile with a moderate yield supported by consistent growth over the past five years. While several financial metrics illustrate stability, investors should observe potential implications on future dividend sustainability amidst changing financial conditions. Careful consideration should be placed on payout ratios and market conditions.
📊 Overview
Elevance Health Inc., a prominent entity in its sector, boasts a notable dividend history and yield, indicative of its commitment to returning value to shareholders.
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Dividend Yield | 1.75% |
| Current Dividend per Share | 6.89 USD |
| Dividend History | 16 years |
| Last Cut or Suspension | None |
📉 Dividend History
The dividend history offers insights into the company's financial discipline and ability to reward shareholders. A consistent history of dividend payments is a positive indicator of the company's stability and profitability.
| Year | Dividend per Share (USD) |
|---|---|
| 2026 | 3.44 |
| 2025 | 6.84 |
| 2024 | 6.52 |
| 2023 | 5.92 |
| 2022 | 5.12 |
📈 Dividend Growth
Dividend growth is a critical measure of ongoing financial health and future stability. An upward trend in dividend growth reflects positively on the company's commitment to its shareholders and future prospects.
| Time | Growth |
|---|---|
| 3 years | 10.14% |
| 5 years | 12.47% |
The average dividend growth is 12.47% over 5 years. This shows moderate but steady dividend growth.
🗣️ Payout Ratio
Payout ratios, both EPS and FCF-based, are key indicators of a company's ability to sustain dividend payments. A balanced ratio suggests strong operational health and dividend sustainability.
| Key Figure | Ratio (%) |
|---|---|
| EPS-based | 28.99% |
| Free Cash Flow-based | 23.21% |
The EPS-based payout ratio of 28.99% and FCF-based ratio of 23.21% suggest that Elevance maintains a sustainable dividend policy with room for growth.
🗣️ Cashflow & Capital Efficiency
Evaluation of cash flow and capital efficiency highlights the company's internal resource management and financial agility, key for sustaining operations and strategic investments.
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Free Cash Flow Yield | 6.16% | 5.30% | 4.08% |
| Earnings Yield | 5.45% | 6.96% | 7.28% |
| CAPEX to Operating Cash Flow | 16.08% | 21.63% | 26.01% |
| Stock-based Compensation to Revenue | 0.17% | 0.11% | 0.14% |
| Free Cash Flow / Operating Cash Flow Ratio | 83.92% | 78.37% | 73.98% |
The healthy free cash flow and capital management reflect Elevance's financial discipline and operational resilience.
🗣️ Balance Sheet & Leverage Analysis
A detailed analysis of the balance sheet and leverage provides insights into Elevance's capital structure and its capacity to withstand economic fluctuations.
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Debt-to-Equity | 67.81% | 79.15% | 75.74% |
| Debt-to-Assets | 24.47% | 27.98% | 27.36% |
| Debt-to-Capital | 40.41% | 44.18% | 43.10% |
| Net Debt to EBITDA | 1.92x | 2.33x | 2.46x |
| Current Ratio | 0.97 | 1.10 | 1.24 |
| Quick Ratio | 0.97 | 1.10 | 1.24 |
| Financial Leverage | 2.77 | 2.83 | 2.77 |
Elevance's balance sheet metrics suggest manageable leverage and strong liquidity, which supports its capacity for strategic financial maneuvering.
📈 Fundamental Strength & Profitability
Key profitability ratios provide an understanding of Elevance's operational efficiency and capacity for financial return, influencing its overall investment appeal.
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Return on Equity | 15.23% | 14.47% | 12.90% |
| Return on Assets | 5.50% | 5.12% | 4.66% |
| Margins: Net | 3.49% | 3.38% | 2.84% |
| Margins: EBIT | 5.10% | 5.14% | 4.07% |
| Margins: EBITDA | 6.12% | 5.93% | 4.85% |
| Margins: Gross | 27.44% | 27.85% | 25.56% |
Strong profit margins and returns indicate efficient resource utilization, positioning Elevance competitively among its peers.
📉 Price Development
Dividend Scoring System
| Criteria | Score | Indicator |
|---|---|---|
| Dividend Yield | 3 | |
| Dividend Stability | 4 | |
| Dividend Growth | 3 | |
| Payout Ratio | 5 | |
| Financial Stability | 4 | |
| Dividend Continuity | 5 | |
| Cashflow Coverage | 4 | |
| Balance Sheet Quality | 4 |
Total Score: 32/40
✅ Rating
Overall, Elevance Health Inc. presents a stable dividend profile. Their strong financials, coupled with a healthy balance sheet, suggest dividend continuity and growth potential. For income-focused investors, ELV represents a solid opportunity with a reassuring track record of shareholder returns.
Smart Data Insight
Master the Perfect Entry & Exit for this Stock
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.
- ✅ Identify the "Golden Buying Window"
- ✅ Avoid high-risk correction cycles
- ✅ Backtested data from the last 20+ years